Fueled by pandemic frustrations, populist parties are embracing anti-vaccine figures — in the U.S. and elsewhere.

The new study is the largest yet to test whether there’s a link between child development and COVID vaccination or infection ...

Europe needs to spend around 250 billion euros ($261.6 billion) annually in defence investments to secure itself without U.S.

"As COVID-19 remains an unpredictable global threat, CSL is dedicated to completing these technical enhancements and making this innovative vaccine available in Europe as soon as possible," he added.

CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...

KOSTAIVE is the first sa-mRNA COVID-19 vaccine to receive approval from the European Commission (EC). KOSTAIVE is currently marketed in Japan against COVID-19. The European Commission approval ...

Moderna Inc. (NASDAQ:MRNA) reported a fourth-quarter EPS loss of $(2.91), missing the consensus of $(2.62), a turnaround from ...

Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with the ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The rate of antiviral prescriptions was 67% lower in pregnant than in nonpregnant women, including those with 1 or more ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

KOSTAIVE is the first sa-mRNA COVID-19 vaccine to receive approval from the European Commission (EC). KOSTAIVE is currently marketed in Japan against COVID-19. The European Commission approval ...